Clinical Trial Supply And Logistics Market Size, Share, Opportunities, And Trends By Component (Manufacturing, Packaging and Labeling, Distribution), By End-User Industry (Pharmaceutical, Biologics, Medical Device), And By Geography - Forecasts From 2025 To 2030

Clinical Trial Supply And Logistics Market Size:

The Clinical Trial Supply And Logistics Market is expected to increase from USD 5.310 billion in 2025 to USD 7.538 billion in 2030, with a 7.26% CAGR.

Clinical Trial Supply And Logistics Market Trends:

In the medical industry, the phase of research that requires a trial of the end product to measure the safety of the drug is known as a clinical trial. Each clinical trial requires distinguished and clean equipment to derive results. Clinical trial and logistic service providers aim to provide support and equipment for clinical trials to the research institute to yield fruitful results. The service providers also manage the trial sites and contact the patients on which the drug can be tested. The prime reason driving the growth of the market is the rising cases of diseases and problems and the need to develop drugs to cure infected patients.  Further, robust growth in the industry through the launch of new channels to deliver the services is predicted to open up new opportunities in the market. However, the high initial cost and requirement of a skilled workforce limit the scope of new entrants. The players in the industry who offer similar products face threats and hence are highly competitive.

Clinical Trial Supply And Logistics Market Growth Drivers:

• Rising drug research is projected to increase the demand in the market.

One of the prime reasons supporting the market growth during the forecasted period is the surging investment in drug research and the rise in drug research projects globally. While the initial drug research is funded by the nation’s government, the later stage, precisely, the clinical trial and following stage research is funded by pharmaceutical companies or through a venture capitalist. Increasing complicities of diseases accompanied by rising diseases instance and surging investment in the drug development industry is projected to support the market growth during the forecasted period.

In India, R&D spending by pharmaceutical companies has been increasing significantly. The spending increased from 7% of sales in 2015 to 8.6% of sales in 2019. Furthermore, considerable growth in sales of the Indian pharmaceutical industry is expected to further increase the market.

• The lack of substitutes is an advantage for the players in the market.

The vendors in the global clinical trial supply and logistics market are enjoying a significantly high power attributable to the lack of substitutes in the landscape. Although some drug development companies may choose to keep this part of the overall drug research and development process in-house, very low cost-efficiency and very high risks associated with the unavailability of the right supplies in the right quantity and quality where and when required have, for long, kept them at bay. The increasing focus of drug development companies on reducing costs and minimizing risks has nearly driven them out of this market. As a result of the lack of substitutes in the market, the suppliers hold an upper position.

Clinical Trial Supply And Logistics Market Geographical Outlook:

• The North American and European clinical trial and logistics supply market is projected to dominate the market.

Based on geography, the global clinical trial and the logistic market are segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. It is expected that the North America and Europe clinical trial and the logistic market will dominate the global industry owing to the larger concentration of pharmaceutical research industries. The Asia Pacific market is forecasted to grow at a significant rate.

Market Segmentation:

• By Service Type
  • Manufacturing
  • Packaging & Labeling
  • Storing
  • Others
• By Clinical Phase
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
• By Application
  • Oncology
  • Cardiology
  • Respiratory Disease
  • CNS & Mental Disorders
  • Others
• By End-User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY SERVICE TYPE

5.1. Introduction

5.2. Manufacturing

5.3. Packaging & Labeling

5.4. Storing

5.5. Others

6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY CLINICAL PHASE

6.1. Introduction

6.2. Phase 1

6.3. Phase 2

6.4. Phase 3

6.5. Phase 4

7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Cardiology

7.4. Respiratory Disease

7.5. CNS & Mental Disorders

7.6. Others

8. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY END-USER

8.1. Introduction

8.2. Pharmaceutical & Biotechnology Companies

8.3. Contract Research Organization (CRO)

8.4. Others

9. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Italy

9.4.5. Spain

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Taiwan

9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. DHL International GmbH

11.2. Marken

11.3. Parexel International Corporation

11.4. Movianto

11.5. Catalent Inc.

11.6. Thermo Fisher Scientific Inc.

11.7. Almac Group

11.8. FedEx

11.9. PCI Pharma Service

11.10. Sharp Services, LLC

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

DHL International GmbH

Marken

Parexel International Corporation

Movianto

Catalent Inc.

Thermo Fisher Scientific Inc.

Almac Group

FedEx

PCI Pharma Service

Sharp Services, LLC

Sorry, the research methodology content could not be loaded.